EWA
TARA icon

EverSource Wealth Advisors’s Protara Therapeutics TARA Stock Holding History

EverSource Wealth Advisors’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03K Buy
269
+139
+107% +$661 ﹤0.01% 3953
2026
Q1 		$678 Buy
+130
New +$769 ﹤0.01% 3976

Other funds holding TARA

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

EverSource Wealth Advisors's TARA Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Protara Therapeutics (TARA) stake by 107% in Q2 2026, buying an estimated $661 and bringing the position to 269 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #3953.

EverSource Wealth Advisors first reported a position in TARA in Q1 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • EverSource Wealth Advisors held 269 shares of Protara Therapeutics worth $1.03K as of Q2 2026.
  • EverSource Wealth Advisors bought 139 Protara Therapeutics shares in Q2 2026, an estimated $661.
  • Protara Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3953 holding.
  • EverSource Wealth Advisors first reported a position in Protara Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.